MIT Sloan logo MIT logo

Research



to


How Often Do Vaccine Trials Hit Paydirt?

NPO Investing: Bigger Funds, Bigger Risks, Bigger Returns

The Drug Dreams Cause Euphoria

5 Ways The World Fought Back

What Drives Outperformance at Endowments & Foundations

Statistical Approach to COVID-19 Clinical Trials Aims to Accelerate Drug Approval Process

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

Vaccines More Likely To Get Through Clinical Trials Than Other Types Of Drugs, MIT Study Finds

MIT Sloan Study Shows Larger Nonprofit Endowment Funds Generate Higher Returns

The Resilient Investor

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | ...36 |